I think CTAD was great for Anavex coming out with positive data showing improvement over SOC. Also learning that sleep is now an endpoint in all three trials. If even half the people in the trials sleep better that will be a benefit to the World and Anavex. But we have a strong suspicion it will be more than half and the best thing is, it doesn’t take an MRI or Precision Medicine to detect. That’s just Real World Evidence that someone paying attention will see in a short time. That makes me sleep better just thinking about it.
Thanks to Penny, Plex and others for the great news and links..
When the Market takes the bait and the hook is set, it's going to be a wild ride.
So, what happens if early outcomes of the Australian Phase 3 trial of Anavex 2-73 are so good that the Australian health authority decides to make the drug available for prescription to the general public?
Which of these headlines might appear in the US?
“Australians Gamble On New Alzheimer’s Drug”
“Untested, Unproven Drug Now Being Forced on Alzheimer’s Patients?
“In Desperation, Australia Lunges For An Answer to Alzheimer’s”
Or, could they be any of these?
“Early Release of New Drug Solves Australian Alzheimer’s Problem”
“Drug Trial Stopped — Australians Have New Alzheimer’s Treatment”
“Drug Trial Results Too Good; Slammed Shut. Drug Now Available”